Xueqin Ma

Title: Xueqin Ma: Innovator in Pharmaceutical Research

Introduction

Xueqin Ma is a prominent inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative compounds for medical applications. With a total of 3 patents to his name, his work focuses on addressing critical health issues.

Latest Patents

Xueqin Ma's latest patents include groundbreaking inventions such as the N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor. This invention encompasses a pharmaceutical composition and its uses, particularly in treating diseases caused by hepatitis B virus infection. The patent details a compound of formula I or II, which may include various forms such as stereoisomers, tautomers, and pharmaceutically acceptable salts. Another patent by Ma also focuses on a similar N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, emphasizing its medical applications in combating hepatitis B virus-related diseases.

Career Highlights

Xueqin Ma is associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he has been instrumental in advancing pharmaceutical innovations. His expertise in the field has led to the development of effective treatments that benefit patients suffering from viral infections.

Collaborations

Xueqin Ma has collaborated with notable colleagues such as Yinsheng Zhang and Wangwei Ao, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Xueqin Ma's contributions to pharmaceutical research highlight his commitment to improving healthcare through innovative solutions. His patents reflect a deep understanding of complex medical challenges and a dedication to finding effective treatments.